Alzheimer – Pipeline Products by Stage of Development 24
Alzheimer – Pipeline Products by Territory 25
Alzheimer – Pipeline Products by Regulatory Path 26
Alzheimer – Pipeline Products by Estimated Approval Date 27
Alzheimer – Ongoing Clinical Trials 28
Alzheimer Companies – Pipeline Products by Stage of Development 29
Alzheimer – Pipeline Products by Stage of Development 35
5M Biomed LLC Pipeline Products & Ongoing Clinical Trials Overview 40
Liquid Biopsy Assay – Alzheimer’s Disease – Product Status 40
Liquid Biopsy Assay – Alzheimer’s Disease – Product Description 40
AC Immune SA Pipeline Products & Ongoing Clinical Trials Overview 41
Abeta-Based Diagnostic Test – Alzheimer´s Disease – Product Status 41
Abeta-Based Diagnostic Test – Alzheimer´s Disease – Product Description 41
pTau-Based Diagnostic Test – Alzheimer´s Disease – Product Status 42
pTau-Based Diagnostic Test – Alzheimer´s Disease – Product Description 42
Acobiom Pipeline Products & Ongoing Clinical Trials Overview 43
Companion Diagnostic Test – Alzheimer’s Disease – Product Status 43
Companion Diagnostic Test – Alzheimer’s Disease – Product Description 43
Diagnostic/Prognostic Assay – Alzheimer’s Disease – Product Status 44
Diagnostic/Prognostic Assay – Alzheimer’s Disease – Product Description 44
Acumen Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 45
Ultra-High Sensitivity Companion Diagnostic Assay – Product Status 45
Ultra-High Sensitivity Companion Diagnostic Assay – Product Description 45
Adlyfe Inc Pipeline Products & Ongoing Clinical Trials Overview 46
Diagnostic Assay – Alzheimer’s Disease – Product Status 46
Diagnostic Assay – Alzheimer’s Disease – Product Description 46
Admit Therapeutics SL Pipeline Products & Ongoing Clinical Trials Overview 47
Diagnostic Test – Alzheimer’s Disease – Product Status 47
Diagnostic Test – Alzheimer’s Disease – Product Description 47
ADx NeuroSciences NV Pipeline Products & Ongoing Clinical Trials Overview 48
ADDL’S Biomarker Test – Product Status 48
ADDL’S Biomarker Test – Product Description 49
Biomarker Assay – Amyloid Ratio High Sensitivity – Product Status 49
Biomarker Assay – Amyloid Ratio High Sensitivity – Product Description 49
Biomarker Assay – P-Tau Isoforms – Product Status 50
Biomarker Assay – P-Tau Isoforms – Product Description 50
Biomarker Assay – Tau Isoforms – Product Status 50
Biomarker Assay – Tau Isoforms – Product Description 50
Biomarker Test – O-TAU – Product Status 51
Biomarker Test – O-TAU – Product Description 51
Biomarker Test – SNAP 25 – Product Status 51
Biomarker Test – SNAP 25 – Product Description 51
Biomarker Test – Synuclein Oligo – Product Status 52
Biomarker Test – Synuclein Oligo – Product Description 52
Blood Based Amyloid Beta Biomarker Test – Product Status 52
Blood Based Amyloid Beta Biomarker Test – Product Description 52
GLOB. P3N Aß Biomarker Test – Product Status 53
GLOB. P3N Aß Biomarker Test – Product Description 53
NfL Test – Alzheimer’s Disease – Product Status 53
NfL Test – Alzheimer’s Disease – Product Description 54
Aelan Cell Technologies Pipeline Products & Ongoing Clinical Trials Overview 55
Diagnostic Blood Test – Alzheimer’s Disease – Product Status 55
Diagnostic Blood Test – Alzheimer’s Disease – Product Description 55
Agent Biotech Pipeline Products & Ongoing Clinical Trials Overview 56
Diagnostic Test – Alzheimer’s Disease – Product Status 56
Diagnostic Test – Alzheimer’s Disease – Product Description 56
Agent Biotech – Ongoing Clinical Trials Overview 57
Diagnostic Test – Alzheimer’s Disease – A Study of Blood-based Detection of Early-stage Alzheimer’s Using Multiomics and Machine Learning 58
Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview 59
Mitochondrial Preprotein Based Test – Alzheimer’s Disease – Product Status 59
Mitochondrial Preprotein Based Test – Alzheimer’s Disease – Product Description 59
Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 60
Diagnostic Assay – Alzheimer’s Disease – Product Status 60
Diagnostic Assay – Alzheimer’s Disease – Product Description 60
AltPep Corp Pipeline Products & Ongoing Clinical Trials Overview 61
SOBA-AD Assay – Product Status 61
SOBA-AD Assay – Product Description 61
Alzheon Inc Pipeline Products & Ongoing Clinical Trials Overview 62
Diagnostic Assay – Alzheimer’s Disease – Product Status 62
Diagnostic Assay – Alzheimer’s Disease – Product Description 62
Alzhyme Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 63
Diagnostic Test – Alzheimer’s Disease – Product Status 63
Diagnostic Test – Alzheimer’s Disease – Product Description 63
Alzinova AB Pipeline Products & Ongoing Clinical Trials Overview 64
ALZ-201-Based Diagnostic Test – Product Status 64
ALZ-201-Based Diagnostic Test – Product Description 64
Amarantus Bioscience Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 65
NuroPro – Alzheimer’s Disease – Product Status 65
NuroPro – Alzheimer’s Disease – Product Description 65
Amarantus Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 66
Georgetown Assay – Alzheimer’s Disease-Exosomes – Product Status 66
Georgetown Assay – Alzheimer’s Disease-Exosomes – Product Description 66
Ambergen Inc Pipeline Products & Ongoing Clinical Trials Overview 67
PC-PURE Immunoassay – Alzheimer’s Disease – Product Status 67
PC-PURE Immunoassay – Alzheimer’s Disease – Product Description 67
Amco International Manufacturing Inc. Pipeline Products & Ongoing Clinical Trials Overview 68
Georgetown Assay – Alzheimer’s Disease-Lipids – Product Status 68
Georgetown Assay – Alzheimer’s Disease-Lipids – Product Description 68
Amoneta Diagnostics SAS Pipeline Products & Ongoing Clinical Trials Overview 69
ADDIA Diagnostic Kit – Alzheimer’s Disease – Product Status 69
ADDIA Diagnostic Kit – Alzheimer’s Disease – Product Description 69
Amprion Inc Pipeline Products & Ongoing Clinical Trials Overview 70
Diagnostic Assay – Alzheimer’s Disease – Product Status 70
Diagnostic Assay – Alzheimer’s Disease – Product Description 70
Applied NeuroSolutions, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 71
P-Tau 231 Test – Product Status 71
P-Tau 231 Test – Product Description 71
Arkley Biotek LLC Pipeline Products & Ongoing Clinical Trials Overview 72
Blood Test – Alzheimer’s Disease – Product Status 72
Blood Test – Alzheimer’s Disease – Product Description 72
Ascent Bio-Nano Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 73
Acoustofluidic Device – Alzheimer’s Disease – Product Status 73
Acoustofluidic Device – Alzheimer’s Disease – Product Description 73
attyloid GmbH Pipeline Products & Ongoing Clinical Trials Overview 74
sFIDA – Product Status 74
sFIDA – Product Description 74
Banyan Biomarkers Inc Pipeline Products & Ongoing Clinical Trials Overview 75
Diagnostic Assay – Alzheimer’s Disease – Product Status 75
Diagnostic Assay – Alzheimer’s Disease – Product Description 75
Beaumont Health System Pipeline Products & Ongoing Clinical Trials Overview 76
AI-Based Blood Test – Alzheimer’s Disease – Product Status 76
AI-Based Blood Test – Alzheimer’s Disease – Product Description 76
BioArctic AB Pipeline Products & Ongoing Clinical Trials Overview 77
Diagnostic Test – Alzheimer’s Disease – Product Status 77
Diagnostic Test – Alzheimer’s Disease – Product Description 77
Bioasis Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 78
Cognitest – Product Status 78
Cognitest – Product Description 78
Biocross SL Pipeline Products & Ongoing Clinical Trials Overview 79
e4Quant Plus Test – Product Status 79
e4Quant Plus Test – Product Description 79
e4Quant Test – Product Status 80
e4Quant Test – Product Description 80
e4Risk Test – Product Status 80
e4Risk Test – Product Description 81
Biocross SL – Ongoing Clinical Trials Overview 82
e4Risk Test – Study of the Predictive Markers and the Pathophysiological Mechanisms of Alzheimer’s Disease: Transverse and Longitudinal Approach in Anatomical and Functional Multimodal Imaging 83
Biois Corp Pipeline Products & Ongoing Clinical Trials Overview 84
AptaSign – Alzheimer’s Disease – Product Status 84
AptaSign – Alzheimer’s Disease – Product Description 84
Biomedical Development Corp Pipeline Products & Ongoing Clinical Trials Overview 85
Vestibular – Topographical Memory Diagnostic Test – Product Status 85
Vestibular – Topographical Memory Diagnostic Test – Product Description 85
BioSystems International Pipeline Products & Ongoing Clinical Trials Overview 86
Diagnostic Test – Alzheimer’s Disease – Product Status 86
Diagnostic Test – Alzheimer’s Disease – Product Description 86
Boston University Medical Campus Pipeline Products & Ongoing Clinical Trials Overview 87
Diagnostic Test – Alzheimer’s Disease – Product Status 87
Diagnostic Test – Alzheimer’s Disease – Product Description 87
Brigham and Women’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 88
NT1 Assay – Product Status 88
NT1 Assay – Product Description 88
C2N Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 89
Multi-Analyte Combination Assay – Product Status 89
Multi-Analyte Combination Assay – Product Description 89
p-tau217 Blood Test – Product Status 90
p-tau217 Blood Test – Product Description 90
C2N Diagnostics LLC – Ongoing Clinical Trials Overview 91
p-tau217 Blood Test – The Swedish Biofinder 2 Study 92
Calviri Inc Pipeline Products & Ongoing Clinical Trials Overview 93
Immunosignaturing Test – Alzheimer’s Disease – Product Status 93
Immunosignaturing Test – Alzheimer’s Disease – Product Description 93
Cassava Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 94
SavaDx – Product Status 94
SavaDx – Product Description 94
Cassava Sciences Inc – Ongoing Clinical Trials Overview 95
SavaDx – Validation/Disease Specificity Study of SavaDx for the Detection of Alzheimer’s Disease 96
Cayman Chemical Co Pipeline Products & Ongoing Clinical Trials Overview 97
Diagnostic Assay Kit – Alzheimer’s Disease – Product Status 97
Diagnostic Assay Kit – Alzheimer’s Disease – Product Description 97
Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 98
Companion Diagnostic Test – Alzheimer’s Disease – Product Status 98
Companion Diagnostic Test – Alzheimer’s Disease – Product Description 98
Cleveland Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 99
Blood-Based Diagnostic Test – Alzheimer’s Disease – Product Status 99
Blood-Based Diagnostic Test – Alzheimer’s Disease – Product Description 99
Cognext Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 100
NPTX2 ELISA Assay – Alzheimer’s Disease – Product Status 100
NPTX2 ELISA Assay – Alzheimer’s Disease – Product Description 100
Columbia University Pipeline Products & Ongoing Clinical Trials Overview 101
Diagnostic Test – Alzheimer’s Disease – Product Status 101
Diagnostic Test – Alzheimer’s Disease – Product Description 101
Cx Precision Medicine Inc Pipeline Products & Ongoing Clinical Trials Overview 102
Alzheimer’s Disease Rule-Out Test – Product Status 102
Alzheimer’s Disease Rule-Out Test – Product Description 102
Alzheimer’s Therapeutic Matching Test – Product Status 103
Alzheimer’s Therapeutic Matching Test – Product Description 103
Amyloid Test – Product Status 103
Amyloid Test – Product Description 104
Confirmatory AD Test – Product Status 104
Confirmatory AD Test – Product Description 104
Cymedx Pipeline Products & Ongoing Clinical Trials Overview 105
Diagnostic Assay – Alzheimer’s Disease – Product Status 105
Diagnostic Assay – Alzheimer’s Disease – Product Description 105
Cytox Ltd Pipeline Products & Ongoing Clinical Trials Overview 106
ADpredict Screening Test – Product Status 106
ADpredict Screening Test – Product Description 106
genoSCORE – Product Status 107
genoSCORE – Product Description 107
genoTOR – Product Status 107
genoTOR – Product Description 108
Diadem SRL Pipeline Products & Ongoing Clinical Trials Overview 109
AlzoSure Confirm – Product Status 109
AlzoSure Confirm – Product Description 109
Alzosure Predict – Product Status 110
Alzosure Predict – Product Description 110
DiamiR LLC Pipeline Products & Ongoing Clinical Trials Overview 111
CogniMIR – Product Status 111
CogniMIR – Product Description 111
DiaPat GmbH Pipeline Products & Ongoing Clinical Trials Overview 112
DiaPat – Alzheimer’s Disease Test – Product Status 112
DiaPat – Alzheimer’s Disease Test – Product Description 112
Durin Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 113
Diagnostic Test – Alzheimer’s Disease – Product Status 113
Diagnostic Test – Alzheimer’s Disease – Product Description 113
Early Alzheimer’s Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 114
Diagnostic Tool – Alzheimer’s Disease – Product Status 114
Diagnostic Tool – Alzheimer’s Disease – Product Description 114
Emory University Pipeline Products & Ongoing Clinical Trials Overview 115
Diagnostic Test – Alzheimer’s Disease – Product Status 115
Diagnostic Test – Alzheimer’s Disease – Product Description 115
Eurobio Scientific SA Pipeline Products & Ongoing Clinical Trials Overview 116
EHT Dx23 – Product Status 116
EHT Dx23 – Product Description 116
Florida Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 117
Diagnostic Test – Alzheimer’s Disease – Product Status 117
Diagnostic Test – Alzheimer’s Disease – Product Description 117
French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview 118
HTRF Test – Alzheimer Disease – Product Status 118
HTRF Test – Alzheimer Disease – Product Description 118
Fujirebio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 119
Lumipulse G – Total TAU – Product Status 119
Lumipulse G – Total TAU – Product Description 119
Lumipulse G ß-Amyloid Ratio (1-42/1-40) – Product Status 120
Lumipulse G ß-Amyloid Ratio (1-42/1-40) – Product Description 120
Lumipulse G1200 – ß-amyloid 1-42 – Product Status 120
Lumipulse G1200 – ß-amyloid 1-42 – Product Description 121
GenoScreen SAS Pipeline Products & Ongoing Clinical Trials Overview 122
Diagnostic Test – Alzheimer’s Disease – Product Status 122
Diagnostic Test – Alzheimer’s Disease – Product Description 122
Ghent University Pipeline Products & Ongoing Clinical Trials Overview 123
Cerebrospinal Fluid Test – Alzheimer’s Disease – Product Status 123
Cerebrospinal Fluid Test – Alzheimer’s Disease – Product Description 123
IBM Research-Australia Pipeline Products & Ongoing Clinical Trials Overview 124
Blood Test – Alzheimer’s Disease – Product Status 124
Blood Test – Alzheimer’s Disease – Product Description 124
ICDD-sas Pipeline Products & Ongoing Clinical Trials Overview 125
ADFlag – Product Status 125
ADFlag – Product Description 125
ADselect – Product Status 126
ADselect – Product Description 126
Inbiomed Pipeline Products & Ongoing Clinical Trials Overview 127
Ubiquitin And SUMO Traps Assay – Alzheimer’s Disease – Product Status 127
Ubiquitin And SUMO Traps Assay – Alzheimer’s Disease – Product Description 127
Innovative Health Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 128
IHD-Amy Blood Test – Alzheimer’s Disease – Product Status 128
IHD-Amy Blood Test – Alzheimer’s Disease – Product Description 128
Inscopix Inc Pipeline Products & Ongoing Clinical Trials Overview 129
Alzheimer’s Disease Assay – Product Status 129
Alzheimer’s Disease Assay – Product Description 129
Instituto de Estructura de la Materia Pipeline Products & Ongoing Clinical Trials Overview 130
Blood-Based Diagnostic Test – Alzheimer’s Disease – Product Status 130
Blood-Based Diagnostic Test – Alzheimer’s Disease – Product Description 130
Integrated Diagnostics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 131
Multiplexed Proteomic Assay – Alzheimer’s Disease – Product Status 131
Multiplexed Proteomic Assay – Alzheimer’s Disease – Product Description 131
Intelligent OMICS Ltd Pipeline Products & Ongoing Clinical Trials Overview 132
Biomarker Assay – Alzheimer’s Disease – Product Status 132
Biomarker Assay – Alzheimer’s Disease – Product Description 132
Janssen Pharmaceutica NV Pipeline Products & Ongoing Clinical Trials Overview 133
Diagnostic Biosignatures – Alzheimer’s Disease – Product Status 133
Diagnostic Biosignatures – Alzheimer’s Disease – Product Description 133
Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 134
BACE1 Diagnostic Assay – Product Status 134
BACE1 Diagnostic Assay – Product Description 134
Johns Hopkins University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview 135
NPTX2 Biomarker Assay – Alzheimer’s Disease – Product Status 135
NPTX2 Biomarker Assay – Alzheimer’s Disease – Product Description 135
KineMed Inc Pipeline Products & Ongoing Clinical Trials Overview 136
Diagnostic Assay – Alzheimer’s Disease – Product Status 136
Diagnostic Assay – Alzheimer’s Disease – Product Description 136
King’s College London Pipeline Products & Ongoing Clinical Trials Overview 137
Monitoring Assay – Alzheimer’s Disease – Product Status 137
Monitoring Assay – Alzheimer’s Disease – Product Description 137
Lund University Pipeline Products & Ongoing Clinical Trials Overview 138
Blood Test – Alzheimer’s Disease – Product Status 138
Blood Test – Alzheimer’s Disease – Product Description 138
P-tau181 Test – Product Status 139
P-tau181 Test – Product Description 139
McGill University Health Center Pipeline Products & Ongoing Clinical Trials Overview 140
Diagnostic Test – Alzheimer’s Disease – Product Status 140
Diagnostic Test – Alzheimer’s Disease – Product Description 140
Medifron DBT Inc Pipeline Products & Ongoing Clinical Trials Overview 141
Next Generation Diagnostic Test – Alzhemier’s Disease – Product Status 141
Next Generation Diagnostic Test – Alzhemier’s Disease – Product Description 141
Memory Dx LLC Pipeline Products & Ongoing Clinical Trials Overview 142
REDx Test – Product Status 142
REDx Test – Product Description 142
Meso Scale Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 143
Biomarker Assay – Alzheimer’s Disease – Product Status 143
Biomarker Assay – Alzheimer’s Disease – Product Description 143
Metabolon Inc Pipeline Products & Ongoing Clinical Trials Overview 144
Diagnostic Test – Alzheimer’s Disease – Product Status 144
Diagnostic Test – Alzheimer’s Disease – Product Description 144
Michigan State University Pipeline Products & Ongoing Clinical Trials Overview 145
Diagnostic Test – Alzheimer’s Disease – Product Status 145
Diagnostic Test – Alzheimer’s Disease – Product Description 145
MYND Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 146
Diagnostic Test – Alzheimer’s Disease – Product Status 146
Diagnostic Test – Alzheimer’s Disease – Product Description 146
Myriad RBM Inc Pipeline Products & Ongoing Clinical Trials Overview 147
Diagnostic Test – Alzheimer’s Disease – Product Status 147
Diagnostic Test – Alzheimer’s Disease – Product Description 147
NanoSomiX Inc Pipeline Products & Ongoing Clinical Trials Overview 148
Diagnostic Panel – Alzheimer’s Disease – Product Status 148
Diagnostic Panel – Alzheimer’s Disease – Product Description 148
Exosome-based Blood Test For p-tau – Product Status 149
Exosome-based Blood Test For p-tau – Product Description 149
Nanosphere Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 150
Ultra-Sensitive Assay – Alzheimer’s Disease – Product Status 150
Ultra-Sensitive Assay – Alzheimer’s Disease – Product Description 150
National Research Foundation of Korea Pipeline Products & Ongoing Clinical Trials Overview 151
Carbon Nanotube Sensor – Alzheimer’s Disease – Product Status 151
Carbon Nanotube Sensor – Alzheimer’s Disease – Product Description 151
National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview 152
Amplified Plasmonic Exosome Test – Product Status 152
Amplified Plasmonic Exosome Test – Product Description 152
Navotavo Inc Pipeline Products & Ongoing Clinical Trials Overview 153
BrainWatcher – Product Status 153
BrainWatcher – Product Description 153
Nel ASA Pipeline Products & Ongoing Clinical Trials Overview 154
ADtect PLUS – Product Status 154
ADtect PLUS – Product Description 154
MCItect ULTRA – Product Status 155
MCItect ULTRA – Product Description 155
NeoNeuro SAS Pipeline Products & Ongoing Clinical Trials Overview 156
Aptamarker AD – Product Status 156
Aptamarker AD – Product Description 156
Neuro Bio Ltd Pipeline Products & Ongoing Clinical Trials Overview 157
Companion Diagnostic Test – Alzheimer’s Disease – Product Status 157
Companion Diagnostic Test – Alzheimer’s Disease – Product Description 157
NeuroQuest Ltd Pipeline Products & Ongoing Clinical Trials Overview 158
Definitive Diagnostic Test – Alzheimer’s Disease – Product Status 158
Definitive Diagnostic Test – Alzheimer’s Disease – Product Description 158
NeuroVision Imaging LLC Pipeline Products & Ongoing Clinical Trials Overview 159
Blood-Based Screening Test – Alzheimer’s Disease – Product Status 159
Blood-Based Screening Test – Alzheimer’s Disease – Product Description 159
Newcastle University Pipeline Products & Ongoing Clinical Trials Overview 160
Olfactory Diagnostic Test – Alzheimer’s Disease – Product Status 160
Olfactory Diagnostic Test – Alzheimer’s Disease – Product Description 160
Novel Bio-spectrum Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 161
NBT Diagnostic Test – Alzheimer’s Disease – Product Status 161
NBT Diagnostic Test – Alzheimer’s Disease – Product Description 161
Numares AG Pipeline Products & Ongoing Clinical Trials Overview 162
Axinon Test – Alzheimer’s Disease – Product Status 162
Axinon Test – Alzheimer’s Disease – Product Description 162
Oligomerix inc Pipeline Products & Ongoing Clinical Trials Overview 163
Drug Screening Assay – Alzheimer’s Disease – Product Status 163
Drug Screening Assay – Alzheimer’s Disease – Product Description 163
Orasi Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 164
Synchronous Neural Interaction Test – Alzheimer’s Disease – Product Status 164
Synchronous Neural Interaction Test – Alzheimer’s Disease – Product Description 164
Oryzon Genomics SA Pipeline Products & Ongoing Clinical Trials Overview 165
Diagnostic Assay – Alzheimer’s Disease – Product Status 165
Diagnostic Assay – Alzheimer’s Disease – Product Description 165
ORY-2001 Companion Diagnostic Assay – Alzheimer’s Disease – Product Status 166
ORY-2001 Companion Diagnostic Assay – Alzheimer’s Disease – Product Description 166
Peri Rx Inc Pipeline Products & Ongoing Clinical Trials Overview 167
Saliva Test – Alzheimer’s Disease – Product Status 167
Saliva Test – Alzheimer’s Disease – Product Description 167
Pre Diagnostics AS Pipeline Products & Ongoing Clinical Trials Overview 168
PreDx – Alzheimer’s Disease – Product Status 168
PreDx – Alzheimer’s Disease – Product Description 168
Predemtec GmbH Pipeline Products & Ongoing Clinical Trials Overview 169
Predemtec DX – Product Status 169
Predemtec DX – Product Description 169
ProMIS Neurosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 170
Companion Diagnostic Test – Alzheimer’s Disease – Product Status 170
Companion Diagnostic Test – Alzheimer’s Disease – Product Description 170
NfL Test – Alzheimer’s Disease – Product Status 171
NfL Test – Alzheimer’s Disease – Product Description 171
P-tau181 Test – Alzheimer’s Disease – Product Status 171
P-tau181 Test – Alzheimer’s Disease – Product Description 172
Proplex Technologies Llc Pipeline Products & Ongoing Clinical Trials Overview 173
Biomarker Diagnostic Test – Alzheimer’s Disease – Product Status 173
Biomarker Diagnostic Test – Alzheimer’s Disease – Product Description 173
Protagen AG Pipeline Products & Ongoing Clinical Trials Overview 174
Diagnostic Assay – Alzheimer’s Disease – Product Status 174
Diagnostic Assay – Alzheimer’s Disease – Product Description 174
Proteome Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview 175
10 Protein MCI/AD Panel – Product Status 175
10 Protein MCI/AD Panel – Product Description 175
Alzheimer’s CSF 3-Plex Assay – Product Status 176
Alzheimer’s CSF 3-Plex Assay – Product Description 176
Diagnostic Assay – Alzheimer’s Disease (CSF) – Product Status 176
Diagnostic Assay – Alzheimer’s Disease (CSF) – Product Description 177
Proteomics International Laboratories Ltd Pipeline Products & Ongoing Clinical Trials Overview 178
Diagnostic Test – Alzheimer’s Disease – Product Status 178
Diagnostic Test – Alzheimer’s Disease – Product Description 178
Quanterix Corp Pipeline Products & Ongoing Clinical Trials Overview 179
NeuroFilament Light Assay – Alzheimer’s Disease – Product Status 179
NeuroFilament Light Assay – Alzheimer’s Disease – Product Description 180
Tau-SIMOA Assay – ADRD – Product Status 180
Tau-SIMOA Assay – ADRD – Product Description 180
Tau-SIMOA Assay – Alzheimer’s Disease – Product Status 181
Tau-SIMOA Assay – Alzheimer’s Disease – Product Description 181
Ultrasensitive Test – Alzheimer’s Disease – Product Status 181
Ultrasensitive Test – Alzheimer’s Disease – Product Description 182
Redox Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 183
Diagnostic Assay – Alzheimer’s Disease – Product Status 183
Diagnostic Assay – Alzheimer’s Disease – Product Description 183
Roche Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 184
Blood Test – Alzheimer’s Disease – Product Status 184
Blood Test – Alzheimer’s Disease – Product Description 184
Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 185
Diagnostic Test – Alzheimer’s Disease – Product Status 185
Diagnostic Test – Alzheimer’s Disease – Product Description 185
Elecsys Amyloid Plasma Panel – Product Status 186
Elecsys Amyloid Plasma Panel – Product Description 186
Elecsys Phospho-Tau (181P) CSF – Product Status 186
Elecsys Phospho-Tau (181P) CSF – Product Description 187
Elecsys ß-Amyloid (1-42) CSF – Product Status 187
Elecsys ß-Amyloid (1-42) CSF – Product Description 187
Rockefeller University Pipeline Products & Ongoing Clinical Trials Overview 188
APP-C99 Biomarker Test – Alzheimer’s Disease – Product Status 188
APP-C99 Biomarker Test – Alzheimer’s Disease – Product Description 188
Ruhr-University Bochum Pipeline Products & Ongoing Clinical Trials Overview 189
Blood Test – Alzheimer’s disease – Product Status 189
Blood Test – Alzheimer’s disease – Product Description 189
Scanogen Inc Pipeline Products & Ongoing Clinical Trials Overview 190
Diagnostic Assay – Alzheimer’s Disease – Product Status 190
Diagnostic Assay – Alzheimer’s Disease – Product Description 190
Scout Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 191
Diagnostic Test – Alzheimer’s Disease – Product Status 191
Diagnostic Test – Alzheimer’s Disease – Product Description 191
Seer Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 192
Diagnostic Test – Alzheimer’s Disease – Product Status 192
Diagnostic Test – Alzheimer’s Disease – Product Description 192
Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview 193
Amyloid Beta 1-42 Based Alzheimer’s Test – Product Status 193
Amyloid Beta 1-42 Based Alzheimer’s Test – Product Description 193
Tau Biomarker Based Alzheimer’s Test – Product Status 194
Tau Biomarker Based Alzheimer’s Test – Product Description 194
Spanish National Research Council Pipeline Products & Ongoing Clinical Trials Overview 195
Diagnostic Assay – Alzheimer’s Disease – Product Status 195
Diagnostic Assay – Alzheimer’s Disease – Product Description 195
StageZero Life Sciences Ltd Pipeline Products & Ongoing Clinical Trials Overview 196
Biomarker Diagnostic Test – Alzheimer’s Disease – Product Status 196
Biomarker Diagnostic Test – Alzheimer’s Disease – Product Description 196
Sugentech Inc Pipeline Products & Ongoing Clinical Trials Overview 197
Diagnostic Test – Alzheimer’s Disease – Product Status 197
Diagnostic Test – Alzheimer’s Disease – Product Description 197
Synaptogenix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 198
Diagnostic Assay – Alzheimer’s Disease – Product Status 198
Diagnostic Assay – Alzheimer’s Disease – Product Description 198
TauRx Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview 199
Diagnostic Test – Alzheimer’s Disease – Product Status 199
Diagnostic Test – Alzheimer’s Disease – Product Description 199
Telo Genomics Corp Pipeline Products & Ongoing Clinical Trials Overview 200
3D Telo-AD Test – Product Status 200
3D Telo-AD Test – Product Description 200
The Florey Institute of Neuroscience and Mental Health Pipeline Products & Ongoing Clinical Trials Overview 201
Companion Diagnostic Test – Alzheimer’s Disease – Product Status 201
Companion Diagnostic Test – Alzheimer’s Disease – Product Description 201
The Hong Kong University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview 202
Blood Test – Alzheimer’s Disease – Product Status 202
Blood Test – Alzheimer’s Disease – Product Description 202
The University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 203
Early Warning Test – Alzheimer’s Disease – Product Status 203
Early Warning Test – Alzheimer’s Disease – Product Description 203
Todos Medical Pipeline Products & Ongoing Clinical Trials Overview 204
LymPro Test – Product Status 204
LymPro Test – Product Description 204
Todos Medical – Ongoing Clinical Trials Overview 205
LymPro Test – A Study to Evaluate the Relationship Between LymPro Test with Amyloid PET Imaging in Mild Cognitive Impairment and Dementia Patients 206
TopoGEN Inc Pipeline Products & Ongoing Clinical Trials Overview 207
Peripheral Blood Biomarker Assay – Alzheimer’s Disease – Product Status 207
Peripheral Blood Biomarker Assay – Alzheimer’s Disease – Product Description 207
Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 208
Diagnostic Test – Alzheimer’s Disease – Product Status 208
Diagnostic Test – Alzheimer’s Disease – Product Description 208
University of Calgary Pipeline Products & Ongoing Clinical Trials Overview 209
Blood Test – Alzheimer’s Disease – Product Status 209
Blood Test – Alzheimer’s Disease – Product Description 209
University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 210
ptau181 Test – Alzheimer’s Disease – Product Status 210
ptau181 Test – Alzheimer’s Disease – Product Description 210
University of Chicago Pipeline Products & Ongoing Clinical Trials Overview 211
EdNd Diagnostic Kit – Alzheimer’s Disease – Product Status 211
EdNd Diagnostic Kit – Alzheimer’s Disease – Product Description 211
University of Georgia Pipeline Products & Ongoing Clinical Trials Overview 212
Diagnostic Assay – Alzheimer’s Disease – Product Status 212
Diagnostic Assay – Alzheimer’s Disease – Product Description 212
University of Gottingen Pipeline Products & Ongoing Clinical Trials Overview 213
Diagnostic Assay – Alzheimer’s Disease – Product Status 213
Diagnostic Assay – Alzheimer’s Disease – Product Description 213
Pyro-Glu-Abeta Peptides Based Diagnostic Assay – Product Status 214
Pyro-Glu-Abeta Peptides Based Diagnostic Assay – Product Description 214
University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 215
Alzheimer’s Disease Diagnostic Test – Product Status 215
Alzheimer’s Disease Diagnostic Test – Product Description 215
Diagnostic Test – Alzheimer’s Disease – Product Status 216
Diagnostic Test – Alzheimer’s Disease – Product Description 216
University of Luxembourg Pipeline Products & Ongoing Clinical Trials Overview 217
Phenotype Assay – Alzheimer’s Disease – Product Status 217
Phenotype Assay – Alzheimer’s Disease – Product Description 217
University of Maryland Baltimore Pipeline Products & Ongoing Clinical Trials Overview 218
Diagnostic Assay – Alzheimer’s Disease – Product Status 218
Diagnostic Assay – Alzheimer’s Disease – Product Description 218
University of Melbourne Pipeline Products & Ongoing Clinical Trials Overview 219
Blood Test – Alzheimer’s Disease – Product Status 219
Blood Test – Alzheimer’s Disease – Product Description 219
University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 220
Blood Based Diagnostic Test – Alzheimer’s Disease – Product Status 220
Blood Based Diagnostic Test – Alzheimer’s Disease – Product Description 220
University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 221
Prognostic Test – Alzheimer’s Disease – Product Status 221
Prognostic Test – Alzheimer’s Disease – Product Description 221
University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview 222
Cell-Ba